Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079603080> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2079603080 endingPage "734" @default.
- W2079603080 startingPage "729" @default.
- W2079603080 abstract "There is limited information on the long-term efficacy and safety of olmesartan medoxomil in the management of hypertension in Chinese patients. We therefore conducted the present multicentre, single-arm, prospective, observational study to investigate the 24-week efficacy and safety of olmesartan medoxomil in patients with mild to moderate hypertension. Eligible patients (diastolic blood pressure [BP] 90–109 mmHg and systolic BP <180 mmHg off antihypertensive medication) were started on olmesartan medoxomil 20 mg once daily, with the possible up-titration to 40 mg once daily during 24 weeks of follow-up, to control clinic BP to the target level (<140/90 and <130/80 mmHg in diabetes mellitus). In a subset of enrolled patients, 24-h ambulatory and home BP monitoring were also performed. In the intent-to-treat analysis (n = 348), at 24 weeks of follow-up, the mean ± SD changes from baseline in clinic systolic/diastolic BP were 21.2 ± 14.2/16.0 ± 8.8 mmHg (p < 0.001). The proportions of patients who achieved the goal BP for systolic, diastolic and both were 81, 80 and 75 %, respectively. Olmesartan medoxomil also significantly (p < 0.001) reduced systolic/diastolic BP measured at patients’ homes by 17.7 ± 13.1/12.1 ± 7.9 mmHg from baseline (n = 109), and reduced mean 24-h, daytime and night-time ambulatory BP by 13.3 ± 16.3/7.6 ± 9.5 mmHg, 13.9 ± 17.4/8.0 ± 10.4 mmHg and 12.3 ± 18.1/6.8 ± 10.2 mmHg, respectively (n = 87). Seven (2.0 %) serious adverse events were reported during follow-up. In Chinese hypertensive patients, olmesartan medoxomil is efficacious in lowering BP as assessed by three different BP-measuring methods and has an acceptable long-term safety and tolerability profile." @default.
- W2079603080 created "2016-06-24" @default.
- W2079603080 creator A5007992547 @default.
- W2079603080 creator A5027860856 @default.
- W2079603080 creator A5044941594 @default.
- W2079603080 creator A5046791973 @default.
- W2079603080 creator A5055388661 @default.
- W2079603080 creator A5055481715 @default.
- W2079603080 date "2012-09-07" @default.
- W2079603080 modified "2023-10-03" @default.
- W2079603080 title "Long-Term Efficacy of Olmesartan Medoxomil in Chinese Hypertensive Patients as Assessed by Clinic, Ambulatory and Home Blood Pressure Measurements" @default.
- W2079603080 cites W1976734710 @default.
- W2079603080 cites W1984645428 @default.
- W2079603080 cites W1991600742 @default.
- W2079603080 cites W1995861586 @default.
- W2079603080 cites W2044113777 @default.
- W2079603080 cites W2045173804 @default.
- W2079603080 cites W2053932973 @default.
- W2079603080 cites W2072318450 @default.
- W2079603080 cites W2075700248 @default.
- W2079603080 cites W2083435278 @default.
- W2079603080 cites W2101062299 @default.
- W2079603080 cites W2152077553 @default.
- W2079603080 doi "https://doi.org/10.1007/s40261-012-0003-7" @default.
- W2079603080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3693426" @default.
- W2079603080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23018282" @default.
- W2079603080 hasPublicationYear "2012" @default.
- W2079603080 type Work @default.
- W2079603080 sameAs 2079603080 @default.
- W2079603080 citedByCount "5" @default.
- W2079603080 countsByYear W20796030802013 @default.
- W2079603080 countsByYear W20796030802014 @default.
- W2079603080 countsByYear W20796030802016 @default.
- W2079603080 crossrefType "journal-article" @default.
- W2079603080 hasAuthorship W2079603080A5007992547 @default.
- W2079603080 hasAuthorship W2079603080A5027860856 @default.
- W2079603080 hasAuthorship W2079603080A5044941594 @default.
- W2079603080 hasAuthorship W2079603080A5046791973 @default.
- W2079603080 hasAuthorship W2079603080A5055388661 @default.
- W2079603080 hasAuthorship W2079603080A5055481715 @default.
- W2079603080 hasBestOaLocation W20796030801 @default.
- W2079603080 hasConcept C126322002 @default.
- W2079603080 hasConcept C149323552 @default.
- W2079603080 hasConcept C164705383 @default.
- W2079603080 hasConcept C188816634 @default.
- W2079603080 hasConcept C2779766728 @default.
- W2079603080 hasConcept C35785553 @default.
- W2079603080 hasConcept C57900726 @default.
- W2079603080 hasConcept C71924100 @default.
- W2079603080 hasConcept C84393581 @default.
- W2079603080 hasConceptScore W2079603080C126322002 @default.
- W2079603080 hasConceptScore W2079603080C149323552 @default.
- W2079603080 hasConceptScore W2079603080C164705383 @default.
- W2079603080 hasConceptScore W2079603080C188816634 @default.
- W2079603080 hasConceptScore W2079603080C2779766728 @default.
- W2079603080 hasConceptScore W2079603080C35785553 @default.
- W2079603080 hasConceptScore W2079603080C57900726 @default.
- W2079603080 hasConceptScore W2079603080C71924100 @default.
- W2079603080 hasConceptScore W2079603080C84393581 @default.
- W2079603080 hasIssue "11" @default.
- W2079603080 hasLocation W20796030801 @default.
- W2079603080 hasLocation W20796030802 @default.
- W2079603080 hasLocation W20796030803 @default.
- W2079603080 hasLocation W20796030804 @default.
- W2079603080 hasOpenAccess W2079603080 @default.
- W2079603080 hasPrimaryLocation W20796030801 @default.
- W2079603080 hasRelatedWork W1965119604 @default.
- W2079603080 hasRelatedWork W1977576526 @default.
- W2079603080 hasRelatedWork W2015555924 @default.
- W2079603080 hasRelatedWork W2151526898 @default.
- W2079603080 hasRelatedWork W2161436320 @default.
- W2079603080 hasRelatedWork W2324123234 @default.
- W2079603080 hasRelatedWork W2350269752 @default.
- W2079603080 hasRelatedWork W2359286463 @default.
- W2079603080 hasRelatedWork W2366855467 @default.
- W2079603080 hasRelatedWork W2414038239 @default.
- W2079603080 hasVolume "32" @default.
- W2079603080 isParatext "false" @default.
- W2079603080 isRetracted "false" @default.
- W2079603080 magId "2079603080" @default.
- W2079603080 workType "article" @default.